United States

Takara Bio Inc (4974.T)

4974.T on Tokyo Stock Exchange

29 May 2017
Change (% chg)

¥-18 (-1.20%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Takara Holdings' subsidiary Takara Bio says merger between US-based units
Monday, 27 Mar 2017 02:19am EDT 

Takara Bio Inc <4974.T> : Says the company's wholly owned US-based sub-subsidiary Takara Bio USA Inc plans to merge with co's other two wholly owned US-based sub-subsidiaries Rubicon Genomics Inc and WaferGen Bio-systems Inc, with effective date on March 31 (for Rubicon) and May 31 (for WaferGen)respectively . Says units Rubicon Genomics and WaferGen Bio-systems will be dissolved after transaction .Says the company, Takara Bio Inc, is a consolidated subsidiary of Takara Holdings Inc <2531.T>.  Full Article

Takara Bio launches fully differentiated, Cellartis hiPS beta cells for research use
Wednesday, 24 Aug 2016 09:00am EDT 

Takara Bio Inc <4974.T> :Launch of fully differentiated, Cellartis hiPS beta cells for research use.  Full Article

Takara Bio completes share repurchase
Monday, 13 Jun 2016 09:40pm EDT 

Takara Bio Inc <4974.T> :Says it completes repurchase of 477,600 shares of its common stock, for about 725 million yen in total, on June 14.  Full Article

Wafergen Bio-Systems and Takara Bio signs distribution agreement for Japan
Monday, 6 Jun 2016 04:01pm EDT 

Wafergen Bio-systems Inc :Wafergen Bio-Systems and Takara Bio Inc Announce exclusive distribution agreement for japan.  Full Article

Wafergen to pay Takara Bio USA Holdings termination fee equal to $2 mln
Friday, 13 May 2016 06:25am EDT 

Wafergen Bio-Systems Inc :Upon termination of merger agreement co will be required to pay Takara Bio USA Holdings a cash termination fee equal to $2.0 million.  Full Article

Takara Bio unit to fully acquire WaferGen Bio-systems
Friday, 13 May 2016 03:30am EDT 

Takara Bio <4974.T>:Says its subsidiary Takara Bio USA Holdings Inc. signed a merger agreement to fully acquire WaferGen Bio-systems, Inc at up to $50 million.  Full Article

TAKARA BIO lists on TSE first section
Wednesday, 30 Mar 2016 08:00pm EDT 

TAKARA BIO INC:Says began listing on Tokyo Stock Exchange (TSE) first section from TSE Mothers on March 31.  Full Article

TAKARA BIO to list on TSE first section
Thursday, 24 Mar 2016 03:00am EDT 

TAKARA BIO INC:Says to list on Tokyo Stock Exchange (TSE) first section from March 31.  Full Article

TAKARA BIO raises consolidated mid-year outlook for FY 2016
Monday, 19 Oct 2015 02:00am EDT 

TAKARA BIO INC:Says the company increased the consolidated mid-year outlook for revenue to 13,257 mln yen from 12,706 mln yen, for the fiscal year ending March 2016.Operating profit forecast increased to 684 mln yen from 444 mln yen.Ordinary profit forecast increased to 867 mln yen from 552 mln yen.Net profit forecast increased to 145 mln yen from 10 mln yen.Earnings per share increased to 1.21 yen from 0.08 yen.  Full Article

More From Around the Web

BRIEF-Takara Bio starts first test of Phase II clinical trial of HF10

* Says it started first test of Phase II clinical trial of HF10, which will be used for treatment in patients with unresectable or metastatic melanoma, on May 26